Skip to main content

Advertisement

ADVERTISEMENT

Psychedelic Treatments

News
04/15/2021
A Phase II clinical trial conducted in London found that in a select group of patients, doses of psilocybin produced comparable antidepressant effects as escitalopram, a commonly prescribed medication for the treatment of...
A Phase II clinical trial conducted in London found that in a select group of patients, doses of psilocybin produced comparable antidepressant effects as escitalopram, a commonly prescribed medication for the treatment of...
A Phase II clinical trial...
04/15/2021
Addiction Professional
Ketamine Shows Promise in Treatment of Mental Health, Chronic Pain, Addiction
Perspectives
04/12/2021
A report published by CDC in August 2020 showed huge increases in mental health issues during the time period April-June 2020 compared with the same time period the previous year. Instances of suicidal conditions increased 200%, anxiety...
A report published by CDC in August 2020 showed huge increases in mental health issues during the time period April-June 2020 compared with the same time period the previous year. Instances of suicidal conditions increased 200%, anxiety...
A report published by CDC in...
04/12/2021
Addiction Professional
News
03/17/2021
Psychedelics are seeing a resurgence with a growing body of research exploring the potential of psychedelic-assisted therapy for a variety of clinical applications. But while progress around psychedelics has accelerated in a relatively brief...
Psychedelics are seeing a resurgence with a growing body of research exploring the potential of psychedelic-assisted therapy for a variety of clinical applications. But while progress around psychedelics has accelerated in a relatively brief...
Psychedelics are seeing a...
03/17/2021
Addiction Professional
News
03/16/2021
Survey respondents who reported having tried a classic psychedelic at least once in their lifetime were found to have significantly more positive replies in three measurements of physical health, according to a study published this month in...
Survey respondents who reported having tried a classic psychedelic at least once in their lifetime were found to have significantly more positive replies in three measurements of physical health, according to a study published this month in...
Survey respondents who reported...
03/16/2021
Addiction Professional
News
03/04/2021
Numinus Wellness and global contract research organization Syreon Corp. announced this week that “significant progress” has been made on their compassionate access trial on the use of psilocybin-assisted motivational enhancement therapy to...
Numinus Wellness and global contract research organization Syreon Corp. announced this week that “significant progress” has been made on their compassionate access trial on the use of psilocybin-assisted motivational enhancement therapy to...
Numinus Wellness and global...
03/04/2021
Addiction Professional
News
02/22/2021
Results of the study were published in the Journal of Psychopharmacology.
Results of the study were published in the Journal of Psychopharmacology.
Results of the study were...
02/22/2021
Addiction Professional
News
02/18/2021
Psychedelic medicine biotech firm MindMed has announced it has begun a study for a “neutralizer” technology that could shorten and stop the effects of an LSD trip during therapy, paving the way for an “emergency shut-off switch” for...
Psychedelic medicine biotech firm MindMed has announced it has begun a study for a “neutralizer” technology that could shorten and stop the effects of an LSD trip during therapy, paving the way for an “emergency shut-off switch” for...
Psychedelic medicine biotech...
02/18/2021
Addiction Professional
News
02/08/2021
The Multidisciplinary Association for Psychedelic Studies (MAPS) and Fireside Project, a not-for-profit psychedelic support services organization, on Monday announced plans to launch a national support line to help individuals having...
The Multidisciplinary Association for Psychedelic Studies (MAPS) and Fireside Project, a not-for-profit psychedelic support services organization, on Monday announced plans to launch a national support line to help individuals having...
The Multidisciplinary...
02/08/2021
Addiction Professional
News
02/04/2021
In many ways—and much to the chagrin of psychiatrists—mental illness remains a mystery, Psych Congress co-chair Charles Raison, MD, said in a lengthy interview published by The Sun magazine this month. While there have been significant...
In many ways—and much to the chagrin of psychiatrists—mental illness remains a mystery, Psych Congress co-chair Charles Raison, MD, said in a lengthy interview published by The Sun magazine this month. While there have been significant...
In many ways—and much to the...
02/04/2021
Addiction Professional

Advertisement

Advertisement